2025 年的期刊文章 · 第 14 页

共 1491 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2025-07-17 到 2025-07-04。

按期刊、按主题看 →

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 页

SiM High-Dimensional Latent Variables & Mixtures · 发表于 2025-07-17

A Maximum Likelihood Method for High‐Dimensional Structural Equation Modeling

Alexander Quinter, Xianming Tan, Donglin Zeng, Joseph G. Ibrahim

摘要

Factor analysis provides an intuitive approach for dimension reduction when working with big data, allowing researchers to represent an extensive number of correlated variables via a subset of underlying latent factors. Traditional methods of factor analysis, such as Structural Equation Modeling (SEM) and factor regression, lack properties desirable for analyzing big data, such as the ability to handle high‐dimensionality or the ability to enforce sparsity on the estimates of the factor loading matrices. These methods also assume that the number of latent constructs is known beforehand, a problem unique to factor analysis that often goes unaddressed or overlooked, with ad hoc methods being the most common ways to deal with such a fundamental question. Although recent developments in the literature have attempted to remedy these issues, particularly with regard to expanding SEM to high‐dimensional and sparse applications, there is a noticeable lack of such methods that do so using likelihood theory. To rectify this shortcoming, we propose a new SEM‐based method for estimation that utilizes maximum likelihood theory while simultaneously addressing some of the most common problems associated with big data. We substantiate our method through simulation studies, indicating that the proposed method can correctly identify the latent factors underlying the independent and dependent sets of variables, while also accurately estimating the entries of and enforcing sparsity upon the factor loading matrix estimates. We apply this method to the COVIDiSTRESS Global Survey dataset, a global survey collected to further our understanding of how the COVID‐19 pandemic affected the human experience. Doing so demonstrates the performance of the model while simultaneously identifying the latent constructs intrinsic to the data.

JASA Networks & Graphs Latent Variables & Mixtures Missing Data & Measurement Error · 发表于 2025-07-17

A Latent Variable Model for Individual Degree Measures in Respondent-Driven Sampling

Yibo Wang, Sunghee Lee, Michael R. Elliott

摘要

Respondent-driven sampling (RDS) is widely used to collect data from hidden populations in social and biomedical science. Although RDS may provide comprehensive coverage of the target hidden population through social network recruitment, its non-random sampling process poses challenges for generalizing findings beyond the sample. Current analytical methods rely on the network size (degree) reported by respondents to adjust for unequal sampling probabilities. However, the accuracy of the reported degree is questionable due to reporting errors, evidenced through an unusual frequency of multiples of five and improbably large values. To address this measurement error, we leverage a byproduct of the RDS process (e.g., respondents' recruitment patterns) and develop a novel degree estimator based on a latent variable model of the true degree that accounts for response errors via a reporting mechanism and incorporates recruitment information and external demographic profiles. The effectiveness of the proposed method is demonstrated through a case study and a simulation study, which shows accurate and reliable degree estimates leading to significant improvements in population parameter estimation. *(abstract via PubMed)*

SiM Survival Analysis Testing & Uncertainty Nonparametric & Semiparametric · 发表于 2025-07-15

α$$ \alpha $$‐KIDS: A Novel Feature Evaluation in the Ultrahigh‐Dimensional Right‐Censored Setting, With Application to Head and Neck Cancer

Atika Farzana Urmi, Chenlu Ke, Dipankar Bandyopadhyay

摘要

Recent advances in sequencing technologies have allowed the collection of massive genome‐wide information that substantially enhances the diagnosis and prognosis of head and neck cancer. Identifying predictive markers for survival time is crucial for devising prognostic systems and learning the underlying molecular drivers of the cancer course. In this paper, we introduce ‐KIDS, a model‐free feature screening procedure with false discovery rate (FDR) control for ultrahigh‐dimensional right‐censored data, which is robust against unknown censoring mechanisms. Specifically, our two‐stage procedure initially selects a set of important features with a dual screening mechanism using nonparametric reproducing‐kernel‐based ANOVA statistics, followed by identifying a refined set of features under FDR control through a unified knockoff procedure. The finite sample properties of our method and its novelty (in light of existing alternatives) are evaluated via simulation studies. Furthermore, we illustrate our methodology via application to a motivating right‐censored head and neck (HN) cancer survival data derived from The Cancer Genome Atlas, with further validation on a similar HN cancer data from the Gene Expression Omnibus database. The methodology can be implemented using the R package aKIDS , which is available on GitHub .

SiM Meta-Analysis & Data Integration Missing Data & Measurement Error · 发表于 2025-07-15

Transfer Learning for Error‐Contaminated Poisson Regression Models

Jou‐Chin Wu, Li‐Pang Chen

摘要

Poisson regression model has been a popular approach to characterize the count response and the covariates. With the rapid development of data collections, the additional source information can be easily recorded. To efficiently use the source data to improve the estimation under the original data, the transfer learning method is considered a strategy. However, challenging issues from the given datasets include measurement error and high‐dimensionality in variables, which are not well explored in the context of transfer learning. In this paper, we propose a novel strategy to handle error‐prone count responses and estimate the parameters in measurement error models by using the source data, and then employ the transfer learning method to derive the corrected estimator. Moreover, to improve the prediction and avoid the model uncertainty, we further establish the model averaging strategy. Simulation and breast cancer data studies verify the satisfactory performance of the proposed method and the validity of handling measurement error.

SiM Bayesian Methods Networks & Graphs · 发表于 2025-07-15

Time‐Varying Bayesian Network Meta‐Analysis

Patrick M. LeBlanc, David Banks

摘要

The presence of methicillin‐resistant Staphylococcus Aureus (MRSA) in complicated skin and soft structure infections (cSSSI) is associated with greater health risks and economic costs to patients. There is concern that MRSA is becoming resistant to other “gold standard” treatments such as vancomycin, and there is disagreement about the relative efficacy of vancomycin compared to linezolid. There are several review papers employing Bayesian Network Meta‐Analyses (BNMAs) to investigate which treatments are best for MRSA‐related cSSSIs, but none address time‐based design inconsistencies. This paper proposes a time‐varying BNMA (tBNMA), which models time‐varying treatment effects across studies using a Gaussian Process kernel. A dataset is compiled from nine existing MRSA cSSSI NMA review papers containing 58 studies comparing 19 treatments over 19 years. The tBNMA finds evidence of a non‐linear trend in the treatment effect of vancomycin–it became less effective than linezolid between 2002 and 2007, but has since recovered statistical equivalence.

SiM Other · 发表于 2025-07-15

The Design of Large‐Scale Plasma Donation Trials

Kecheng Li, Richard J. Cook

摘要

Devices for extracting blood from donors require rigorous evaluation for the safety of donors. Complications arise from the fact that outcomes on successive donations from the same donor are not independent, adverse event rates are extremely rare, and there is substantial heterogeneity in the propensity for donors to donate over time. We develop a statistical framework for the design of a superiority trial and a non‐inferiority trial, aiming to demonstrate the safety of a new donation device compared to the standard one. Historical data on the intensity and heterogeneity of donation across donors, the adverse event rate, and the serial dependence in adverse events provide information on how to plan accrual and follow‐up periods to give the expected number of donors and donations. The analysis is based on a binary donation‐specific outcome modeled with a Poisson approximation (i.e., log link and identity variance function) using generalized estimating equations with a working independence assumption. The historical data enables calculation of the asymptotic robust variance estimate, which is used for planning. The formulae derived are found to provide good control of the type I error rate and statistical power. We illustrate the derivations with application to a plasma donation trial aiming to investigate the safety of a new device, with the outcome being serious hypotensive adverse events.

SiM Survival Analysis · 发表于 2025-07-15

Subgroup Testing in the Change‐Plane Cox Model

Xiao Zhang, Panpan Ren, Xingjie Shi, Shuangge Ma, Xu Liu

摘要

Survival outcomes are frequently observed in numerous biomedical and epidemiological studies. The impact of treatment on these outcomes may vary across subgroups characterized by other covariates, for example, immune checkpoint blockade therapy may have different effects on the survival of solid tumor patients based on their tumor mutational burden. In such scenarios, change‐plane Cox models provide a suitable approach to identify subgroups that exhibit an improved treatment effect in the analysis of survival data. While some literature is available for testing the presence of a change plane in these models, the existing methods primarily rely on the score test, which has limited power in small sample situations. In this paper, we introduce a novel method based on the likelihood ratio test to enhance the power. The asymptotic distributions of the proposed test statistic under both the null and local alternative hypotheses are established. Furthermore, the finite sample performance of the proposed approach is comprehensively evaluated through extensive simulation studies. Finally, the proposed test is applied to analyze nonsmall cell lung cancer data, further demonstrating its practical utility.

SiM High-Dimensional Causal Inference · 发表于 2025-07-15

Simultaneous Feature Selection for Optimal Dynamic Treatment Regimens

Mochuan Liu, Yuanjia Wang, Donglin Zeng

摘要

Dynamic treatment regimens (DTRs), where treatment decisions are tailored to individual patient's characteristics and evolving health status over multiple stages, have gained increasing interest in the modern era of precision medicine. Identifying important features that drive these decisions over stages not only leads to parsimonious DTRs for practical use but also enhances the reliability of learning optimal DTRs. Existing methods for learning optimal DTRs, such as Q‐learning and O‐learning, rely on a sequential procedure to estimate the optimal decision at each stage backward. Incorporating feature selection in these methods through regularization at each stage of estimation only identifies unimportant tailoring variables at each stage but is not necessary for those variables that are not important across all the stages. As a result, false discovery errors are likely to accumulate over stages in these sequential methods. To overcome this limitation, we propose a framework, namely L1 multistage ramp loss (L1‐MRL) learning, to learn the optimal decision rules and, at the same time, perform variable selection across all the stages simultaneously. This framework uses a single multistage ramp loss to estimate optimal DTRs for all stages. Furthermore, a group Lasso‐type penalty is imposed to penalize the coefficients in the decision rules across all stages, which enables the identification of features that are important for at least one stage decision. Theoretically, we show that the estimator is consistent and enjoys the oracle property toward the optimal. We demonstrate that the proposed method performs equally well as or better than many existing DTR methods with variable selection capability via extensive simulation studies and an application to electronic health record (EHR) data for type 2 diabetes (T2D) patients.

SiM Clinical Trials · 发表于 2025-07-15

Sample Size Calculations for Partially Clustered Trials

Kylie M. Lange, Jessica Kasza, Thomas R. Sullivan, Lisa N. Yelland

摘要

Partially clustered trials are defined as trials where some observations belong to a cluster and others are independent. For example, neonatal trials may include infants from a single, twin, or triplet birth. The clustering of observations in partially clustered trials should be accounted for when determining the target sample size to avoid being over or underpowered. However, sample size methods have only been developed for limited partially clustered trial designs (e.g., designs with maximum cluster sizes of 2). In this article, we present new design effects that can be used to determine the sample size for two‐arm, parallel, partially clustered trials where clusters exist pre‐randomization. Design effects are derived algebraically for continuous and binary outcomes, assuming a generalized estimating equations‐based approach to estimation with either an independence or exchangeable working correlation structure. Both cluster and individual randomization are considered for the clustered observations. The design effects are shown to depend on the intracluster correlation coefficient, proportion of observations that belong to clusters of each size, method of randomization, type of outcome, and working correlation structure. The design effects are validated through a simulation study. Example sample size calculations are presented to illustrate how the design effects can be used to determine the target sample size for different partially clustered trial designs. The design effects depend on parameters that can be feasibly estimated when planning a trial and can be used to ensure that partially clustered trials are appropriately powered in the future.

SiM Meta-Analysis & Data Integration Genetics & Omics · 发表于 2025-07-15

Robust Transfer Learning for High‐Dimensional GLM Using γ$$ \gamma $$‐Divergence With Applications to Cancer Genomics

Fuzhi Xu, Shuangge Ma, Qingzhao Zhang, Yaqing Xu

摘要

In the analysis of complex diseases, high‐dimensional profiling data is important for assessing risks and detecting biomarkers. With the increasing accessibility of cancer genomic data, the sample sizes remain limited in most studies. Hence, borrowing information from additional data sources is thus desirable to improve estimation and prediction. Transfer learning has been demonstrated to be flexible and effective in boosting modeling performance with a record in biomedical applications. In practice, outliers and even data contamination often occur. However, existing transfer learning methods often lack robustness to outliers and data contamination, issues commonly observed in real‐world biomedical data. In this study, we propose a robust transfer learning approach based on the minimum ‐divergence under a generalized linear model (GLM) framework for high‐dimensional data. Our method incorporates a data‐driven source detection scheme that automatically identifies informative sources while mitigating the risk of negative transfer. We establish rigorous theoretical results, including consistency and high‐dimensional estimation error bounds, ensuring robustness and reliable performance. A computationally efficient algorithm is developed based on proximal gradient descent to facilitate both the transfer and debiasing steps. Simulation demonstrates the superior and competitive performance of the proposed approach in selection and prediction/classification. We further validate its practical utility by analyzing data on breast cancer and glioblastoma, showcasing the method's effectiveness in real‐world high‐dimensional settings.

SiM Bayesian Methods · 发表于 2025-07-15

Robust Bayesian Inference in the Multilevel Zero‐Inflated Generalized Poisson Model

Mekuanint Simeneh Workie, Xu Yi

摘要

Outliers, over‐dispersion, and zero inflation are issues with count data. Traditional models like Poisson and negative binomial often fail to account for these issues, leading to biased estimates and poor model fit. These frameworks are extended by the Zero‐Inflated Generalized Poisson (ZIGP) model, which takes into consideration not only zero inflation but also over‐dispersion or under‐dispersion. However, in the presence of outliers and hierarchical data structures. This study develops a robust Bayesian inference framework for the multilevel ZIGP model. Standard Bayesian methods often lack robustness under model misspecification and in the presence of outlier data. The framework uses a Robust expectation solution (RES) algorithm and generalized Bayesian inference (GBI) for robust estimation against outliers. These approaches improve estimation accuracy using robust loss functions and scaling parameters to minimize the influence of outliers. Simulation studies confirm that the Robust Expectation Solution (RES) algorithm significantly outperformed the Expectation‐Maximization (EM) algorithm in reducing bias and mean squared error (MSE), especially in the presence of outliers. Regular Bayesian and EM algorithms were more sensitive to outliers, leading to potential bias and instability in parameter estimates. Our robust Bayesian framework, specifically the Generalized Bayesian Inference (GBI), demonstrated improved robustness and stability under model misspecification and outlier contamination. The main results show that tuning quantiles and optimizing scaling parameters improved parameter calibration and reduced bias and mean square error (MSE). We applied the framework to neonatal mortality data, identifying key risk factors such as maternal education, wealth status, rural residence, and age at first birth.

SiM Survival Analysis High-Dimensional Genetics & Omics · 发表于 2025-07-15

Penalized Reduced Rank Regression for Multi‐Outcome Survival Data Supports a Common Metabolic Risk Score for Age‐Related Diseases

Marije H. Sluiskes, Hein Putter, Marian Beekman, Jelle J. Goeman, Mar Rodríguez‐Girondo

摘要

The increasing availability of multi‐outcome data in health research presents new opportunities for understanding complex health processes, such as aging. Aging is a multifaceted process, encompassing both lifespan and health span, as well as the onset of age‐related diseases. To model this complexity, we propose the penalized reduced rank regression model for multi‐outcome survival data (penalized survRRR), which identifies shared latent factors driving multiple outcomes. The model imposes a rank constraint on the coefficient matrix to capture underlying mechanisms of aging while accommodating high‐dimensional and correlated predictors and outcomes by introducing penalization. We discuss the statistical properties of this doubly regularized approach and show how the optimal number of ranks can be estimated from the data. We apply a lasso‐penalized reduced rank regression model to 78,553 participants of the UK Biobank, using over 200 metabolic variables as predictors and the onset of seven age‐related diseases and mortality as the outcomes of interest. Our results indicate that a rank 1 model provides the best fit to the data, resulting in a single metabolite‐based score of age‐related disease susceptibility. This highlights the potential of the penalized survRRR model to provide new insights into the nature of the relationship between metabolomics and age‐related diseases.

SiM Diagnostics & Prediction · 发表于 2025-07-15

Optimal Linear Combination of Biomarkers by Weighted Youden Index Maximization

Sizhe Wang, Fang Fang, Jialiang Li

摘要

In medical research, it is common practice to combine various biomarkers to improve the accuracy of disease diagnosis. The weighted Youden index (WYI), which assigns unequal weights to sensitivity and specificity based on their relative importance, serves as an important and flexible evaluation metric of diagnostic tests. However, no existing methods have been designed specifically to identify the optimal linear combination of biomarkers that maximizes the WYI. In this paper, we propose a novel method to construct an optimal diagnosis score and determine the best cut‐off point at the same time. The estimated combination coefficients and cut‐off point are shown to have cube root asymptotics, and their joint limiting distribution is established rigorously. Further, the asymptotic normality of the optimal in‐sample WYI is established, and out‐of‐sample inference for score distribution and comparison is investigated. These results provide deep theoretical insights for methods of Youden index maximization for the first time. Computationally, an iterative marginal optimization algorithm, different from the existing literature, is adopted to deal with the objective function that is neither continuous nor smooth. Simulation studies support the theoretical results and demonstrate the superiority of the proposed method. Two real‐world examples—coronary disease and Alzheimer's disease diagnosis—are presented for illustration.

SiM Causal Inference · 发表于 2025-07-15

Natural Effects in the Presence of an Intermediate Confounder: Evaluation of Pragmatic Estimation Strategies With an Emphasis on the Relationship Between Natural and Interventional Effects

Jesse Gervais, Geneviève Lefebvre, Erica E. M. Moodie

摘要

Mediation analysis using the so‐called natural effects is an essential tool to uncover causal pathways between an exposure and an outcome. However, natural effects are not generally identified in the presence of an intermediate confounder (), a situation that arguably arises frequently in practice. Three pragmatic approaches can be used to estimate natural effects when such a confounder is present: Natural effects estimators that omit , natural effects estimators that consider as a pre‐exposure confounder, or interventional effects estimators. Interventional effects are analogous to natural effects, but remain identified when is present. The goal of this study was two‐fold: (1) to assess the extent to which natural and interventional estimands differ under a variety of data‐generating mechanisms with intermediate confounding and (2) using simulations, to investigate the corresponding performance of the three aforementioned strategies to estimate natural effects. In the continuous outcome case, using interventional effects estimators was found to be a better analytic strategy for estimating natural effects than using standard natural effects estimators when the interaction term between and in the outcome model was null or moderate in comparison to the other parameters. However, the performance of interventional effects declined as the ‐ interaction was increased. In the binary outcome case, the three estimation strategies yielded more similar results than in the continuous outcome case. The difference between the three analytic strategies is illustrated using data from the World Value Survey.

SiM Machine Learning Clinical Trials Causal Inference · 发表于 2025-07-15

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights

Yeonhee Park, Samuel Nycklemoe

摘要

Adaptive randomization is a promising approach in clinical trials that aims to optimize patient outcomes by adjusting treatment allocation probabilities based on accumulating data. However, implementing adaptive randomization in group sequential trials, which include interim analyses for early stopping decisions, poses significant challenges, such as managing type I error inflation and ensuring robust statistical validity. This paper proposes Machine learning‐assisted Adaptive Randomization for Group sequential trials based on Overlap weights (MARGO) as an innovative solution to these challenges. MARGO integrates machine learning (ML) models into the adaptive randomization process, allowing dynamic updates to randomization probabilities based on real‐time predictions of treatment success. To control the overall type I error rate due to the covariate imbalance in group sequential trials, MARGO utilizes overlap weights (OW), which are employed to balance covariates across treatment groups, minimizing confounding and ensuring that the comparison between treatments remains unbiased. In our implementation, various ML algorithms are evaluated for their effectiveness in predicting treatment outcomes. Through extensive simulation studies, we demonstrate that MARGO not only enhances the flexibility and efficiency of group sequential trials but also maintains statistical rigor by effectively controlling type I error rates. Our results show that MARGO provides a more ethical and data‐driven approach to patient allocation, potentially improving treatment success rates while preserving the integrity of the trial.

SiM Missing Data & Measurement Error · 发表于 2025-07-15

Integrating Misclassified EHR Outcomes With Validated Outcomes From a Non‐Probability Sample

Jenny Shen, Dane Isenberg, Kristin A. Linn, Rebecca A. Hubbard

摘要

Although increasingly used for research, electronic health records (EHR) often lack a gold‐standard assessment of key data elements. Linking EHRs to other data sources with higher‐quality measurements can improve statistical inference, but such analyses must account for selection bias if the linked data source arises from a non‐probability sample. We propose a set of novel estimators targeting the average treatment effect (ATE) that combine information from binary outcomes measured with error in a large, population‐representative EHR database with gold‐standard outcomes obtained from a smaller validation sample subject to selection bias. We evaluate our approach in extensive simulations and an analysis of data from the Adult Changes in Thought (ACT) study, a longitudinal study of incident dementia in a cohort of Kaiser Permanente Washington members with linked EHR data. For a subset of deceased ACT participants who consented to brain autopsy prior to death, gold‐standard measures of Alzheimer's disease neuropathology are available. Our proposed estimators reduced bias and improved efficiency for the ATE, facilitating valid inference with EHR data when key data elements are ascertained with error.

SiM Other · 发表于 2025-07-15

Incorporation of Patient and Public Involvement in Statistical Methodology Research: Summary of Workshop Proceedings

Aiden Smith, Hannah Worboys, Samina Begum, Derrick Bennett, Jonathan Broomfield, Suzie Cro, Laura Evans‐Hill, Justin Greenwood, Ania Henley, Mary Mancini, Kara‐Louise Royle, Helen Saul, Jamie Sergeant, Derek Stewart, Freya Tyrer, James Wason, Christopher Yau, Laura J. Gray

摘要

Patient and Public Involvement (PPI) is well‐established in applied health research but remains under utilised in statistical methodology research due to perceived irrelevance and communication challenges. This paper summarises a one‐day workshop held in February 2024 in Leicester, organised by the University of Leicester and the NIHR Statistics Group, aimed at addressing barriers to meaningful PPI in statistical methodology. The workshop brought together statisticians and experienced public contributors to discuss strategies, share case studies, and offer practical guidance on conducting effective PPI. Key barriers identified included: (1) uncertainty about the relevance of PPI in methodology‐focused research; (2) public contributors' anxiety over mathematical complexity; and (3) mismatched expectations due to different backgrounds in applied versus methodological research. Case studies showcased how PPI led to improved model structures, identification of data issues, and enhanced study materials. The importance of communication was a recurrent theme, with recommendations including use of plain English, regular updates, and visual storytelling tools. Feedback from attendees indicated increased confidence and motivation to engage in PPI. Public contributors emphasised the need for respectful, non‐patronising interactions and flexible roles within projects. Recommendations include managing expectations, enhancing accessibility, co‐developing materials, and fostering diversity among contributors. This paper highlights the need for tailored strategies to integrate PPI into statistical methodology, including the development of resources (e.g., glossaries, animations) and further case study collection. Future work will focus on expanding these resources, addressing challenges of equity and inclusion, and supporting PPI in complex methodological areas like simulation and model development.

SiM Survival Analysis Clinical Trials Nonparametric & Semiparametric · 发表于 2025-07-15

Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment

Jiren Sun, Tuo Wang, Yanyao Yi, Ting Ye, Jun Shao, Yu Du

摘要

The area under the curve (AUC) of the mean cumulative function (MCF) has recently been introduced as a novel estimand for evaluating treatment effects in recurrent event settings, offering an alternative to the commonly used Lin‐Wei‐Yang‐Ying (LWYY) model. The AUC of the MCF provides a clinically interpretable summary measure that captures the overall burden of disease progression, regardless of whether the proportionality assumption holds. To improve the precision of the AUC estimation while preserving its unconditional interpretability, we propose a nonparametric covariate adjustment approach. This approach guarantees efficiency gain compared to unadjusted analysis, as demonstrated by theoretical asymptotic distributions, and is universally applicable to various randomization schemes, including both simple and covariate‐adaptive designs. Extensive simulations across different scenarios further support its advantage in increasing statistical power. Our findings highlight the importance of covariate adjustment for the analysis of AUC in recurrent event settings, offering practical guidance for its application in randomized clinical trials.

SiM Clinical Trials Causal Inference · 发表于 2025-07-15

Assessing Mediation in Cross‐Sectional Stepped Wedge Cluster Randomized Trials

Zhiqiang Cao, Fan Li

摘要

Mediation analysis has been studied for independent data, but relatively little work has been done for correlated data observed under stepped wedge cluster randomized trials (SW‐CRTs). Motivated by the need to understand the effect mechanisms in SW‐CRTs, we develop a set of regression‐based methods for conducting mediation analysis. Based on linear and generalized linear mixed models, we explain how to estimate the natural indirect effect and mediation proportion in typical SW‐CRTs with four data type combinations, including both continuous and binary mediators and outcomes. Furthermore, to address potential complexities due to exposure‐time treatment effect heterogeneity, we further derive the mediation expressions in SW‐CRTs when the total effect varies as a function of the exposure time. Simulations show that the proposed mediation estimators perform well across all data type combinations and treatment effect structures. Finally, we illustrate the use of the proposed approach in a real SW‐CRT example. An R package mediateSWCRT has been developed to facilitate the practical implementation of the estimators.

SiM Survival Analysis · 发表于 2025-07-15

An Efficient Estimation Method for Additive Subdistribution Hazards Model With Left‐Truncated Competing Risks Data Under the Case‐Cohort Study Design

Xi Fang, Kwang Woo Ahn, Jianwen Cai, Soyoung Kim

摘要

The case‐cohort study design provides a cost‐effective approach for large cohort studies with competing risks outcomes. The additive subdistribution hazards model assesses direct covariate effects on cumulative incidence when investigating risk differences among different groups instead of relative risk. The presence of left truncation, which commonly occurs in biomedical studies, introduces additional complexities to the analysis. Existing inverse‐probability‐weighting methods for case‐cohort studies on competing risks are inefficient in parameter estimation of coefficients for baseline covariates. In addition, their methods do not address left truncation. To improve the efficiency of parameter estimation of coefficients for baseline covariates and account for left‐truncated competing risks data, we propose an augmented‐inverse‐probability‐weighted estimating equation for left‐truncated competing risks data with additive subdistribution models under the case‐cohort study design. For multiple case‐cohort studies, we further improve parameter estimation efficiency by incorporating extra information from the other causes. We study large sample properties of the proposed estimators. Simulation studies demonstrate the unbiasedness of our proposed estimator and the superior efficiency in regression parameter estimation. We apply the proposed methods to analyze data from the Atherosclerosis Risk in Communities study.

SiM Latent Variables & Mixtures · 发表于 2025-07-15

Agreement Between Two Quantitative Measurement Methods When the Underlying Latent Trait Is Not Constant

Patrick Taffé

摘要

Most statistical methods that have been developed to assess the agreement between two quantitative measurement methods have (implicitly) relied on the assumption of a constant “individual” latent trait. This might be inappropriate when the “individual” is not an object but a person. Therefore, the goal of this study was to extend the standard measurement error model to cope with this limit. Four different settings were investigated: first, where the true individual latent trait was constant; second, where it was variable but without exhibiting a time trend; third, where it followed a linear time trend; and fourth, where it exhibited an approximate linear time trend. Two competing methods to estimate the parameters of the general measurement error model were assessed: the GLS estimator of Sprent and the two‐stage method of Taffé. It was found that the latter generally performed better than the former to estimate the bias. In addition, it can be used when there is only a single measurement per individual by one of the two measurement methods, which is not the case with the former method.

SiM Missing Data & Measurement Error · 发表于 2025-07-15

Adjusting for Selection Bias Due to Missing Data in Electronic Health Records‐Based Research by Blending Multiple Imputation and Inverse Probability Weighting

Tanayott Thaweethai, Rajarshi Mukherjee, David Arterburn, Heidi Fischer, Catherine Lee, Susan M. Shortreed, Sebastien Haneuse

摘要

Due to the complex process by which electronic health records (EHR) are generated and collected, missing data is a significant challenge when conducting large observational studies using such data. However, most standard methods that seek to adjust for the potential selection bias induced by restricting to individuals with complete data fail to address the heterogeneous structure of EHR. To address this, a framework was previously proposed that modularizes the data provenance that gives rise to the observed data as a sequence of decisions made by patients, healthcare providers, and the health system. In this work, we formalize analyses with this framework, specifically by proposing a pragmatic, flexible, and scalable framework for estimation and inference that blends inverse probability weighting and multiple imputation. The proposed framework allows better alignment between consideration of missingness assumptions to the complexity of EHR data. In addition to formal theoretical justification and simulation studies, we illustrate the proposed framework with a motivating data application in which EHR data are used to investigate weight loss outcomes following bariatric surgery, and whether differences between two surgery types exhibit effect modification by presence/absence of chronic kidney disease.

SiM Longitudinal Data · 发表于 2025-07-15

Accounting for Patient Characteristics in a Model‐Based Kappa of Agreement Between Two Experts' Ordinal Ratings

Kerrie P. Nelson, Thomas J. Zhou

摘要

Cohen's kappa and other summary measures are often used in clinical studies to describe agreement and association between two experts' ordered categorical ratings. However, a key limitation of Cohen's kappa and similar measures is their inability to evaluate the impact of patient‐related factors such as family history and age on the agreement and association between experts. Strong agreement between experts is an essential component of effective clinical procedures where subjective interpretation of patients' images or test results by an expert is required, for example, in the visual assessment of breast density from a mammogram. Not accounting for important patient‐related factors can lead to inflated and biased assessments of agreement and association. In this article, our objective is to propose novel model‐based measures that appropriately account for the impact of patient‐related covariates on chance‐corrected agreement and association between two experts' ordinal ratings that overcome limitations of existing measures. Our population‐based approach is based on an ordinal generalized linear mixed model (GLMM). Rigorous simulation studies evaluating performance of the new model‐based measures in a broad range of settings are reported. Existing and new measures are compared in two clinical applications assessing breast density and multiple sclerosis. Key advantages of the new kappa measures over existing measures such as Cohen's kappa include incorporating patient‐related factors, robustness to underlying disease prevalence and marginal distributions of experts' ratings, and appropriately correcting for chance agreement. Sample R code is provided by the authors for application of proposed measures in other studies.

SiM Clinical Trials · 发表于 2025-07-15

A Note on the Sample Size Formula for a Win Ratio Endpoint

Se Yoon Lee

摘要

The sample size formula for a win ratio endpoint proposed by Yu and Ganju is re‐evaluated from an implementation perspective. This formula relies on an approximated null variance, rather than the exact permutation variance originally introduced by Finkelstein and Schoenfeld. As a result, the formula is analytically straightforward, does not require patient‐level data to determine sample size, and is advantageous for practitioners, as it avoids the need for simulations in power analysis. In this paper, we empirically demonstrate that the power based on this sample size formula is generally lower than the power derived using the exact permutation variance across various scenarios. This discrepancy arises primarily due to the overestimation of the true variance when the approximated null variance is used in place of the exact permutation variance. We hope this will encourage further discussion regarding the appropriate application of this formula.

SiM Latent Variables & Mixtures Survival Analysis · 发表于 2025-07-15

A Latent‐Class Model for Time‐To‐Event Outcomes and High‐Dimensional Imaging Data

Jiahui Feng, Haolun Shi, Ma Da, Mirza Faisal Beg, Jiguo Cao

摘要

Structural magnetic resonance imaging (MRI) is one of the primary predictors of Alzheimer's disease risk, enabling the identification of patients with similar risk profiles for precision medicine treatment. Motivated by the need for flexible modeling in AD research, we propose a latent‐class model that addresses the heterogeneity within study populations. This model allows for varying relationships between covariates and survival outcomes, accommodating the dynamics of AD progression. The imaging predictors are characterized by bivariate splines over triangulation to accommodate the irregular domain of the brain images. We develop a generalized expectation‐maximization (EM) algorithm that combines the computational methods for logistic regression and penalized proportional hazards models to implement the proposed approach. We demonstrate the advantages of the proposed method through extensive simulation studies and provide an application to the Alzheimer's Disease Neuroimaging Initiative (ADNI) study, which helps to reveal different subtypes or stages of the disease process in Alzheimer's Disease.

SiM Other · 发表于 2025-07-15

A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design

Cyrus Mehta, Martin Kappler

摘要

We consider the problem of comparing multiple treatment arms to a common control arm over the two stages of a group sequential randomized clinical trial. At the end of stage one, arms may be tested and dropped for overwhelming efficacy, futility, safety, or any other arbitrary reason, and the sample sizes of the arms going forward for stage two testing may be adaptively altered. At the end of stage two, a final analysis is performed, and efficacious treatment arms are identified by a testing procedure that offers strong control of the family‐wise error rate (FWER). Two testing procedures, the ‐value combination method and the conditional error rate method, are discussed theoretically and then compared by simulation. While both procedures control the FWER, the conditional error rate procedure is seen to provide greater power than the ‐value combination procedure for a wide range of scenarios and alternative hypotheses. Plausible reasons for this power differential are given.

SMMR Survival Analysis Nonparametric & Semiparametric · 发表于 2025-07-14

Semiparametric regression analysis of interval-censored failure time data with a cure subgroup and nonignorable missing covariates

Yichen Lou, Mingyue Du, Peijie Wang, Xinyuan Song

摘要

This article discusses regression analysis of interval-censored failure time data in the presence of a cure fraction and nonignorable missing covariates. To address the challenges caused by interval censoring, missing covariates and the existence of a cure subgroup, we propose a joint semiparametric modeling framework that simultaneously models the failure time of interest and the missing covariates. In particular, we present a class of semiparametric nonmixture cure models for the failure time and a semiparametric density ratio model for the missing covariates. A two-step likelihood-based estimation procedure is developed and the large sample properties of the resulting estimators are established. An extensive numerical study demonstrates the good performance of the proposed method in practical settings and the proposed approach is applied to an Alzheimer’s disease study that motivated this study.

SiM Causal Inference Genetics & Omics · 发表于 2025-07-14

Outlier Detection in Mendelian Randomization

Maximilian M. Mandl, Anne‐Laure Boulesteix, Stephen Burgess, Verena Zuber

摘要

Mendelian randomization (MR) uses genetic variants as instrumental variables to infer causal effects of exposures on an outcome. One key assumption of MR is that the genetic variants used as instrumental variables are independent of the outcome conditional on the risk factor and unobserved confounders. Violations of this assumption, that is, the effect of the instrumental variables on the outcome through a path other than the risk factor included in the model (which can be caused by pleiotropy), are common phenomena in human genetics. Genetic variants, which deviate from this assumption, appear as outliers to the MR model fit and can be detected by the general heterogeneity statistics proposed in the literature, which are known to suffer from overdispersion, that is, too many genetic variants are declared as false outliers. We propose a method that corrects for overdispersion of the heterogeneity statistics in uni‐ and multivariable MR analysis by making use of the estimated inflation factor to correctly remove outlying instruments and therefore account for pleiotropic effects. Our method is applicable to summary‐level data.

SiM Testing & Uncertainty · 发表于 2025-07-14

Multivariate Adjustments for Average Equivalence Testing

Younes Boulaguiem, Luca Insolia, Maria‐Pia Victoria‐Feser, Dominique‐Laurent Couturier, Stéphane Guerrier

摘要

Multivariate (average) equivalence testing is widely used to assess whether the means of two conditions of interest are “equivalent” for different outcomes simultaneously. In pharmacological research for example, many regulatory agencies require the generic product and its brand‐name counterpart to have equivalent means both for the AUC and C max pharmacokinetics parameters. The multivariate Two One‐Sided Tests (TOST) procedure is typically used in this context by checking if, outcome by outcome, the marginal confidence intervals for the difference in means between the two conditions of interest lie within predefined lower and upper equivalence limits. This procedure, already known to be conservative in the univariate case, leads to a rapid power loss when the number of outcomes increases, especially when one or more outcome variances are relatively large. In this work, we propose a finite‐sample adjustment for this procedure, the multivariate ‐TOST, that consists in a correction of , the significance level, taking the (arbitrary) dependence between the outcomes of interest into account and making it uniformly more powerful than the conventional multivariate TOST. We present an iterative algorithm allowing to efficiently define , the corrected significance level, a task that proves challenging in the multivariate setting due to the inter‐relationship between and the sets of values belonging to the null hypothesis space and defining the test size. We study the operating characteristics of the multivariate ‐TOST both theoretically and via an extensive simulation study considering cases relevant for real‐world analyses—that is, relatively small sample sizes, unknown and possibly heterogeneous variances as well as different correlation structures—and show the superior finite‐sample properties of the multivariate ‐TOST compared to its conventional counterpart. We finally re‐visit a case study on ticlopidine hydrochloride and compare both methods when simultaneously assessing bioequivalence for multiple pharmacokinetic parameters.

SiM Nonparametric & Semiparametric Missing Data & Measurement Error · 发表于 2025-07-14

Ascertainment Conditional Maximum Likelihood for Continuous Outcome Under Two‐Phase Response‐Selective Design

Gustavo Amorim, Ran Tao, Thomas Lumley, Pamela A. Shaw, Bryan E. Shepherd

摘要

Data collection procedures are often time‐consuming and expensive. An alternative to collecting full information from all subjects enrolled in a study is a two‐phase design: Variables that are inexpensive or easy to measure are obtained for the study population, and more specific, expensive, or hard‐to‐measure variables are collected only for a well‐selected sample of individuals. Often, only these subjects that provided full information are used for inference, while those that were partially observed are discarded from the analysis. Recently, semiparametric approaches that use the entire dataset, resulting in fully efficient estimators, have been proposed. These estimators, however, have challenges incorporating multiple covariates, are computationally expensive, and depend on tuning parameters that affect their performance. In this paper, we propose an alternative semiparametric estimator that does not pose any distributional assumptions on the covariates or measurement error mechanism and can be applied to a wider range of settings. Although the proposed estimator is not semiparametric efficient, simulations show that the loss of efficiency to estimate the parameters associated with the partially observed covariates is minimal. We highlight the estimator's applicability to real‐world problems, where data structures are complex and rich, and complicated regression models are often necessary.

Biometrics Survival Analysis · 发表于 2025-07-13

Multiple tests for restricted mean time lost with competing risks data

Merle Munko, Dennis Dobler, Marc Ditzhaus

摘要

Easy-to-interpret effect estimands are highly desirable in survival analysis. In the competing risks framework, one good candidate is the restricted mean time lost (RMTL). It is defined as the area under the cumulative incidence function up to a prespecified time point and, thus, it summarizes the cumulative incidence function into a meaningful estimand. While existing RMTL-based tests are limited to 2-sample comparisons and mostly to 2 event types, we aim to develop general contrast tests for factorial designs and an arbitrary number of event types based on a Wald-type test statistic. Furthermore, we avoid the often-made, rather restrictive continuity assumption on the event time distribution. This allows for ties in the data, which often occur in practical applications, for example, when event times are measured in whole days. In addition, we develop more reliable tests for RMTL comparisons that are based on a permutation approach to improve the small sample performance. In a second step, multiple tests for RMTL comparisons are developed to test several null hypotheses simultaneously. Here, we incorporate the asymptotically exact dependence structure between the local test statistics to gain more power. The small sample performance of the proposed testing procedures is analyzed in simulations and finally illustrated by analyzing a real-data example about leukemia patients who underwent bone marrow transplantation.

SMMR Clinical Trials Longitudinal Data · 发表于 2025-07-13

Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs

Florence Loingeville, Manel Rakez, Thu Thuy Nguyen, Mark Donnelly, Lanyan Fang, Kevin Feng, Liang Zhao, Stella Grosser, Guoying Sun, Wanjie Sun, France Mentré, Julie Bertrand

摘要

In pharmacokinetic (PK) bioequivalence (BE) analysis, the recommended approach is the two one-sided tests (TOSTs) on non-compartmental analysis (NCA) estimates of area under the plasma drug concentration versus time curve and C m a x (NCA-TOST). Sample size estimation for a BE study requires assumptions on between/within subject variability (B/WSV). When little prior information is available, interim analysis using two-stage group sequential (GS) or adaptive designs (ADs) may be beneficial. GS fixes the second stage size, while AD requires sample re-estimation based on first-stage results. Recent research has proposed model-based (MB) TOST, using nonlinear mixed effects models, as an alternative to NCA-TOST. This work extends GS and AD approaches to MB-TOST. We evaluated these approaches on simulated parallel and two-way crossover designs for a one-compartment PK model, considering three variability levels for initial sample size calculation. We compared final sample size, type I error, and power estimates from one-stage, GS, and AD designs using NCA-TOST and MB-TOST. Results showed both NCA-TOST and MB-TOST reasonably controlled type I error while maintaining adequate power in two-stage GS and AD approaches, based on our limited computation power. Two-stage designs reduced sample size compared to traditional designs, especially for highly variable drugs, with many trials stopping at Stage 1 in AD designs. Our findings suggest MB-TOST may serve as a viable alternative to NCA-TOST for BE assessment in two-stage designs, especially when B/WSV impacts BE results.

JASA Networks & Graphs · 发表于 2025-07-10

Network Goodness-of-Fit for the Block-Model Family

Jiashun Jin, Zheng Tracy Ke, Jiajun Tang, Jingming Wang

摘要

The block-model family has four popular network models (SBM, DCBM, MMSBM, and DCMM). A fundamental problem is, how well each of these models fits with real networks. We propose GoF-MSCORE as a new Goodness-of-Fit (GoF) metric for DCMM (the broadest one among the four), with two main ideas. The first is to use cycle count statistics as a general recipe for GoF. The second is a novel network fitting scheme. GoF-MSCORE is a flexible GoF approach, and we further extend it to SBM, DCBM, and MMSBM. This gives rise to a series of GoF metrics covering each of the four models in the block-model family.We show that for each of the four models, if the assumed model is correct, then the corresponding GoF metric converges to N(0,1) as the network sizes diverge. We also analyze the powers and show that these metrics are optimal in many settings. In comparison, many other GoF ideas face challenges: they may lack a parameter-free limiting null, or are non-optimal in power, or face an analytical hurdle. Note that a parameter-free limiting null is especially desirable as many network models have a large number of unknown parameters. The limiting nulls of our GoF metrics are always N(0,1), which are parameter-free as desired.For 12 frequently-used real networks, we use the proposed GoF metrics to show that DCMM fits well with almost all of them. We also show that SBM, DCBM, and MMSBM do not fit well with many of these networks, especially when the networks are relatively large. To complement with our study on GoF, we also show that the DCMM is nearly as broad as the rank-K network model. Based on these results, we recommend the DCMM as a promising model for undirected networks. *(abstract via OpenAlex)*

Biometrika Clinical Trials Causal Inference Testing & Uncertainty · 发表于 2025-07-10

Leveraging external data for testing experimental therapies with biomarker interactions in randomized clinical trials

B Ren, F Ferrari, S Fortini, S Ventz, L Trippa

摘要

Summary: In oncology the efficacy of novel therapeutics often differs across patient subgroups, and these variations are difficult to predict during the initial phases of the drug development process. The relation between the power of randomized clinical trials and heterogeneous treatment effects has been discussed by several authors. In particular, false negative results are likely to occur when the treatment effects concentrate in a subpopulation, but the study design did not account for potential heterogeneous treatment effects. The use of external data from completed clinical studies and electronic health records has the potential to improve decision-making throughout the development of new therapeutics, from early-stage trials to registration. Here we discuss the use of external data to evaluate experimental treatments with potential heterogeneous treatment effects. We introduce a permutation procedure to test, at the completion of a randomized clinical trial, the null hypothesis that the experimental therapy does not improve the primary outcomes in any subpopulation. The permutation test leverages the available external data to increase power. Also, the procedure controls the false positive rate at the desired $ \alpha $ level without restrictive assumptions on the external data, for example, in scenarios with unmeasured confounders, different pretreatment patient profiles in the trial population compared to the external data and other discrepancies between the trial and external data. We illustrate that the permutation test is optimal according to an interpretable criteria and discuss examples based on asymptotic results and simulations, followed by a retrospective analysis of individual patient-level data from a collection of glioblastoma clinical trials.

JASA Spatial & Time Series Meta-Analysis & Data Integration Bayesian Methods · 发表于 2025-07-10

Adaptation Using Spatially Distributed Gaussian Processes

Botond Szabo, Amine Hadji, Aad van der Vaart

摘要

We consider the accuracy of an approximate posterior distribution in nonparametric regression problems by combining posterior distributions computed on subsets of the data defined by the locations of the independent variables. We show that this approximate posterior retains the rate of recovery of the full data posterior distribution, where the rate of recovery adapts to the smoothness of the true regression function. As particular examples we consider Gaussian process priors based on integrated Brownian motion and the Matérn kernel augmented with a prior on the length scale. Besides theoretical guarantees we present a numerical study of the methods both on synthetic and real world data. We also propose a new aggregation technique, which numerically outperforms previous approaches. Finally, we demonstrate empirically that spatially distributed methods can adapt to local regularities, potentially outperforming the original Gaussian process. *(abstract via OpenAlex)*

SMMR Testing & Uncertainty Survival Analysis Causal Inference · 发表于 2025-07-09

Inference procedures in sequential trial emulation with survival outcomes: Comparing confidence intervals based on the sandwich variance estimator, bootstrap and jackknife

Juliette M Limozin, Shaun R Seaman, Li Su

摘要

Sequential trial emulation (STE) is an approach to estimating causal treatment effects by emulating a sequence of target trials from observational data. In STE, inverse probability weighting is commonly utilised to address time-varying confounding and/or dependent censoring. Then structural models for potential outcomes are applied to the weighted data to estimate treatment effects. For inference, the simple sandwich variance estimator is popular but conservative, while nonparametric bootstrap is computationally expensive, and a more efficient alternative, linearised estimating function (LEF) bootstrap, has not been adapted to STE. We evaluated the performance of various methods for constructing confidence intervals (CIs) of marginal risk differences in STE with survival outcomes by comparing the coverage of CIs based on nonparametric/LEF bootstrap, jackknife, and the sandwich variance estimator through simulations. LEF bootstrap CIs demonstrated better coverage than nonparametric bootstrap CIs and sandwich-variance-estimator-based CIs with small/moderate sample sizes, low event rates and low treatment prevalence, which were the motivating scenarios for STE. They were less affected by treatment group imbalance and faster to compute than nonparametric bootstrap CIs. With large sample sizes and medium/high event rates, the sandwich-variance-estimator-based CIs had the best coverage and were the fastest to compute. These findings offer guidance in constructing CIs in causal survival analysis using STE.

SMMR Survival Analysis Clinical Trials · 发表于 2025-07-09

Health utility adjusted survival: A composite endpoint for clinical trial designs

Yangqing Deng, John de Almeida, Wei Xu

摘要

Many randomized trials have used overall survival as the primary endpoint for establishing non-inferiority of one treatment compared to another. However, if a treatment is non-inferior to another treatment in terms of overall survival, clinicians may be interested in further exploring which treatment results in better health utility scores for patients. Examining health utility in a secondary analysis is feasible, however, since health utility is not the primary endpoint, it is usually not considered in the sample size calculation, hence the power to detect a difference of health utility is not guaranteed. Furthermore, often the premise of non-inferiority trials is to test the assumption that an intervention provides superior quality of life or toxicity profile without compromising survival when compared to the existing standard. Based on this consideration, it may be beneficial to consider both survival and utility when designing a trial. There have been methods that can combine survival and quality of life into a single measure, but they either have strong restrictions or lack theoretical frameworks. In this manuscript, we propose a method called health utility adjusted survival, which can combine survival outcome and longitudinal utility measures for treatment comparison. We propose an innovative statistical framework as well as procedures to conduct power analysis and sample size calculation. By comprehensive simulation studies involving summary statistics from the PET-NECK trial, we demonstrate that our new approach can achieve superior power performance using relatively small sample sizes, and our composite endpoint can be considered as an alternative to overall survival in future clinical trial design and analysis where both survival and health utility are of interest.

SMMR Survival Analysis Survey & Sampling Diagnostics & Prediction · 发表于 2025-07-09

Estimation of receiver operating characteristic curve when case and control require different transformations for normality

Xiaoyu Cai, Wei Zhang, Huiyun Li, Zhaohai Li, Aiyi Liu

摘要

The receiver operating characteristic curve is a popular tool for evaluating the discriminative ability of a diagnostic biomarker. Parametric and nonparametric methods exist in the literature for estimation of a receiver operating characteristic curve and its associated summary measures using data usually collected from a case-control study. Since the receiver operating characteristic curve remains unchanged under a monotone transformation, the biomarker data from both cases (diseased subjects) and controls (non-diseased subjects) are often transformed based on a common Box-Cox transformation (or other appropriate transformation) prior to the application of a parametric estimation method. However, careful examination of the data often reveals that the biomarker values in the diseased and non-diseased population can only be normally approximated via different transformations. In this situation, existing estimation methods cannot be directly applied to the heterogeneously-transformed data. In this article, we deal with the situation that biomarker data from both diseased and non-diseased population are normally distributed after being transformed with different Box-Cox transformations. Under this assumption, we show that existing methods based on a common Box-Cox transformation are invalid in that they possess substantial biases. We move on to propose a method to estimate the underlying receiver operating characteristic curve and its area under the curve, and investigate its performance as compared to the nonparametric estimator that ignores any distributional assumptions as well as the estimators based on a common Box-Cox transformation assumptions. The method is exemplified with HIV infection data from the National Health and Nutrition Examination Survey (NHANES).

Biometrika Other · 发表于 2025-07-09

A family of toroidal diffusions with exact likelihood inference

E García-Portugués, M Sørensen

摘要

We provide a class of diffusion processes for continuous time-varying multivariate angular data with explicit transition probability densities, enabling exact likelihood inference. The presented diffusions are time reversible and can be constructed for any prespecified stationary distribution on the torus, including highly multimodal mixtures. We give results on asymptotic likelihood theory, allowing one-sample inference and tests of linear hypotheses for $ k $ groups of diffusions, including homogeneity. We show that exact and direct diffusion bridge simulation is possible too. A class of circular jump processes with similar properties is also proposed. Several numerical experiments illustrate the methodology for the circular and two-dimensional torus cases. The new family of diffusions is applied (i) to test several homogeneity hypotheses on the movement of ants and (ii) to simulate bridges between the three-dimensional backbones of two related proteins.

SMMR Clinical Trials Bayesian Methods · 发表于 2025-07-04

Population-adjusted unanchored indirect comparisons of cancer therapies with borrowing of pan-tumor information

Dylan Maciel, Shannon Cope, Walter Bouwmeester, Chunlin Qian, Beata Korytowsky, Jeroen P Jansen

摘要

In clinical research of cancer therapy for rare mutations, trial designs must be adapted to accommodate the typically small sample sizes, and single-arm and basket trials have gained prominence. In this paper, we apply principles of Bayesian hierarchical methods and multilevel network meta-regression to propose a model for a pairwise population-adjusted unanchored indirect comparison of cancer therapies in different tumor types with borrowing of pan-tumor information. An individual-level regression model is defined for the single-arm trial of the intervention for which we have individual patient data. The aggregate data of the other trial for the competing intervention are fitted by integrating the covariate effects at the individual level over its covariate distribution to form the aggregate likelihood. To improve the estimation of the tumor type-specific relative treatment effects, we assume exchangeability reflecting the belief of a pan-tumor effect. The method is illustrated with a case study of adagrasib versus sotorasib in previously treated KRAS G12C -mutated advanced/metastatic tumors: non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and pancreatic ductal adenocarcinoma (PDAC). Adagrasib was associated with a greater tumor response than sotorasib according to the analyses: The odds ratios were 1.87 (1.21–2.84) for NSCLC; 2.08 (1.22–3.93) for CRC; and 2.02 (1.14–4.05) for PDAC. The analysis illustrated that a reasonably conservative assumption about the degree of similarity can result in more meaningful and interpretable findings. The proposed model allows for population adjustment and information sharing across tumor types when performing an unanchored indirect comparison of interventions for which it is believed a pan-tumor effect holds.

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 页